Search

Your search keyword '"Allen, Timothy Craig"' showing total 722 results
Start Over Author "Allen, Timothy Craig"
722 results on '"Allen, Timothy Craig"'

1. Remote Pathology Practice: The Time for Remote Diagnostic Pathology in This Digital Era is Now

Author

Schukow, Casey P. and Allen, Timothy Craig

Subjects
United States. Centers for Medicare and Medicaid Services -- Powers and duties, Technology application, Powers and duties, Prevention, Forecasts and trends, Market trend/market analysis, Telemedicine -- Forecasts and trends, COVID-19 -- Prevention, Pathology -- Technology application
Abstract

The coronavirus disease 2019 (COVID-19) pandemic exacerbated pathologists' retirement and increased pathologists' burnout, worsening the pathologist shortage. Medicine suffers from an unprecedented and growing pathologist shortage impacting hospital systems and [...]

Published
2024
Full Text
View/download PDF

3. The Cancer Biomarkers Conference: Pathologists Leading the Molecular Testing Discussion

Author

Allen, Timothy Craig

Subjects
Evaluation, Analysis, Conferences, meetings and seminars, Methods, Health care industry, Medical tests -- Evaluation, Cancer screening -- Methods -- Evaluation, Health care industry -- Conferences, meetings and seminars, Biological markers -- Analysis, Cancer -- Diagnosis
Abstract

The Cancer Biomarkers Conference (CBC) was the inspiration of Philip T. Cagle, MD, who quickly recognized the amazing opportunities that would arise, and changes that would ultimately occur in cancer [...]

Published
2024
Full Text
View/download PDF

4. Understanding Factors Associated With Anaplastic Lymphoma Kinase Testing Delays in Patients With Non-Small Cell Lung Cancer in a Large Real-World Oncology Database

Author

Bernicker, Eric H., Xiao, Yan, Croix, Denise A., Yang, Baiyu, Abraham, Anup, Redpath, Stella, Engstrom-Melnyk, Julia, Shah, Roma, and Allen, Timothy Craig

Subjects
Management, Diagnosis, Evaluation, Company business management, Cancer treatment -- Management, Cancer diagnosis -- Management, Cancer research, Anaplastic lymphoma kinase (ALK) inhibitor -- Evaluation, Non-small cell lung cancer -- Diagnosis, Oncology, Experimental, Cancer -- Diagnosis -- Care and treatment -- Research, Lung cancer, Non-small cell -- Diagnosis
Abstract

The identification of driver alterations that can be targeted with oral tyrosine kinase inhibitors has transformed the care of patients with advanced lung cancer. However, treating patients appropriately is contingent [...], Context.--With multiple therapeutic options available for patients with advanced non-small cell lung cancer, the timely ordering and return of results to determine therapy are of critical importance. Objective.--To assess factors impacting anaplastic lymphoma kinase (ALK) test ordering and time to result delivery. Design.--A retrospective study using a de-identified electronic health record database was performed. Post-diagnosis ALK tests (n = 14 657) were analyzed from 14 197 patients with advanced non-small cell lung cancer diagnosed between January 2015 and May 2019. Time from non-small cell lung cancer diagnosis to ALK sample receipt in the laboratory was a surrogate for test order time. Test ordering was considered delayed if order time was more than 20 days. Turnaround time from sample received to test result was calculated and considered delayed if more than 10 days. Multivariable logistic regression was used to assess factors associated with order time and turnaround time delays. Results.--Median ALK test order time was 15 days, and 36.4% (5342) of all 14 657 orders were delayed. Factors associated with delays were non-fluorescence in situ hybridization testing, send-out laboratories, testing prior to 2018, nonadenocarcinoma histology, and smoking history. Median turnaround time was 9 days, and 40.3% (5906) of all 14 657 test results were delayed. Non-fluorescence in situ hybridization testing, tissue sample, and orders combining ALK with other biomarkers were associated with delayed ALK result reporting. Conclusions.--This study provides a snapshot of real-world ALK test ordering and reporting time in US community practices. Multiple factors impacted both test ordering time and return of results, revealing opportunities for improvement. It is imperative that patients eligible for targeted therapy be identified in a timely fashion. (Arch Pathol Lab Med. 2022;146:975-983; doi: 10.5858/arpa.2021-0029-OA)

Published
2022
Full Text
View/download PDF

5. Establishing a Professionalism and Communication Curriculum at the University of Mississippi Medical Center Department of Pathology

Author

Allen, Timothy Craig and Smith, Patrick O.

Subjects
Practice, Diagnosis, Care and treatment, Risk factors, Ethical aspects, Methods, Disruptive mood dysregulation disorder -- Risk factors -- Diagnosis -- Care and treatment, Pathologists -- Practice -- Ethical aspects, Clinical pathology -- Methods
Abstract

'I spoke with the residency director of Pathology. We both agree you'll be a great fit there ... Given your difficulties with communication and social cues I think it will [...]

Published
2022
Full Text
View/download PDF

7. Empyema, Pleural

Author

Allen, Timothy Craig, Zreik, Riyam T., van Krieken, J. H. J. M., Series Editor, Allen, Timothy Craig, editor, and Suster, Saul, editor

Published
2018
Full Text
View/download PDF

8. Localized Pleural Fibrosis

Author

Marquez, Christopher P., Allen, Timothy Craig, van Krieken, J. H. J. M., Series Editor, Allen, Timothy Craig, editor, and Suster, Saul, editor

Published
2018
Full Text
View/download PDF

10. Endometriosis, Pleural

Author

Hayes, Pamela, Allen, Timothy Craig, van Krieken, J. H. J. M., Series Editor, Allen, Timothy Craig, editor, and Suster, Saul, editor

Published
2018
Full Text
View/download PDF

14. Primary Pleural Lymphoma

Author

Romano, Ryan, Allen, Timothy Craig, van Krieken, J. H. J. M., Series Editor, Allen, Timothy Craig, editor, and Suster, Saul, editor

Published
2018
Full Text
View/download PDF

15. Genetic Susceptibility to Lung Cancer

Author

Allen, Timothy Craig, Cagle, Philip T., Series editor, Allen, Timothy Craig, editor, Beasley, Mary Beth, editor, Chirieac, Lucian R., editor, Dacic, Sanja, editor, Borczuk, Alain C., editor, Kerr, Keith M., editor, Sholl, Lynette M., editor, Portier, Bryce, editor, and Bernicker, Eric H., editor

Published
2018
Full Text
View/download PDF

16. Lung Cancer Stem Cells

Author

Allen, Timothy Craig, Cagle, Philip T., Series editor, Allen, Timothy Craig, editor, Beasley, Mary Beth, editor, Chirieac, Lucian R., editor, Dacic, Sanja, editor, Borczuk, Alain C., editor, Kerr, Keith M., editor, Sholl, Lynette M., editor, Portier, Bryce, editor, and Bernicker, Eric H., editor

Published
2018
Full Text
View/download PDF

17. Pathologists Will Prevail

Author

Allen, Timothy Craig

Subjects
Forecasts and trends, Training, Market trend/market analysis, Labor market -- Forecasts and trends, Time
Abstract

'We can't complacently sit back and think that everything is going to be ok.' (1) --Calum McClelland 'Strategy without tactics is the slowest route to victory. Tactics without strategy is [...]

Published
2020
Full Text
View/download PDF

19. Liposarcoma, Primary Pleural

Author

Marquez, Christopher P., Allen, Timothy Craig, van Krieken, J. H. J. M., Series Editor, Allen, Timothy Craig, editor, and Suster, Saul, editor

Published
2018
Full Text
View/download PDF

23. Regulating Artificial Intelligence for a Successful Pathology Future

Author

Allen, Timothy Craig

Subjects
United States. Food and Drug Administration, Artificial intelligence, State laws, Cognition, Physicians, Machinery
Abstract

Artificial intelligence (AI), a set of techniques aimed at approximating some aspect of human cognition using machines, (1) promises to provide pathologists a tool to improve inefficiencies and inaccuracies in [...]

Published
2019
Full Text
View/download PDF

24. The Evolution of Decedent Ownership

Author

Allen, Timothy Craig

Subjects
Ethical aspects, State laws, Property rights, Tissue donation, Organ transplantation, Informed consent
Abstract

'You don't want to invest property rights in human beings ... It is just wrong.' --Al Gore (1) Among the greatest obligations of a pathologist is the requirement that the [...]

Published
2019
Full Text
View/download PDF

26. Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society

Author

Thunnissen, Erik, Allen, Timothy Craig, Adam, Julien, Aisner, Dara L., Beasley, Mary Beth, Borczuk, Alain C., Cagle, Philip T., Capelozzi, Vera Luiza, Cooper, Wendy, Hariri, Lida P., Kern, Izidor, Lantuejoul, Sylvie, Miller, Ross, Mino-Kenudson, Mari, Radonic, Teodora, Raparia, Kirtee, Rekhtman, Natasha, Roy-Chowdhuri, Sinchita, Russell, Prudence, Schneider, Frank, Sholl, Lynette M., Tsao, Ming Sound, Vivero, Marina, and Yatabe, Yasushi

Subjects
Research, Biological markers -- Research, Gene expression -- Research, Pathology -- Research
Abstract

Pulmonary predictive biomarkers are defined as markers for which the results are essential for therapeutic decision making. In the setting of metastatic non-small cell lung cancer (NSCLC), predictive immunohistochemistry (IHC) [...], * The use of immunohistochemistry for the determination of pulmonary carcinoma biomarkers is a well-established and powerful technique. Immunohistochemisty is readily available in pathology laboratories, is relatively easy to perform and assess, can provide clinically meaningful results very quickly, and is relatively inexpensive. Pulmo nary predictive biomarkers provide results essential for timely and accurate therapeutic decision making; for patients with metastatic non-small cell lung cancer, predictive immunohistochemistry includes ALK and programmed death ligand-1 (PD-L1) (ROS1, EGFR in Europe) testing. Handling along proper methodologic lines is needed to ensure patients receive the most accurate and representative test outcomes.(Arch Pathol Lab Med. 2018;142:408-419; doi: 10.5858/arpa.2017-0106-SA)

Published
2018
Full Text
View/download PDF

27. Fibrous Pleural Adhesions

Author

Henrie, Emma, Allen, Timothy Craig, van Krieken, J. H. J. M., Series Editor, Allen, Timothy Craig, editor, and Suster, Saul, editor

Published
2018
Full Text
View/download PDF

28. Thymoma, Pleural

Author

Marquez, Christopher P., Allen, Timothy Craig, van Krieken, J. H. J. M., Series Editor, Allen, Timothy Craig, editor, and Suster, Saul, editor

Published
2018
Full Text
View/download PDF

33. Squamous Cell Carcinoma

Author

Allen, Timothy Craig, Cagle, Philip T., editor, Allen, Timothy Craig, editor, Beasley, Mary Beth, editor, Chirieac, Lucian R., editor, Dacic, Sanja, editor, Borczuk, Alain C., editor, and Kerr, Keith M., editor

Published
2012
Full Text
View/download PDF

34. Genetic Susceptibility to Lung Cancer

Author

Allen, Timothy Craig, Cagle, Philip T., editor, Allen, Timothy Craig, editor, Beasley, Mary Beth, editor, Chirieac, Lucian R., editor, Dacic, Sanja, editor, Borczuk, Alain C., editor, and Kerr, Keith M., editor

Published
2012
Full Text
View/download PDF

35. Lung Cancer Stem Cells

Author

Allen, Timothy Craig, Cagle, Philip T., editor, Allen, Timothy Craig, editor, Beasley, Mary Beth, editor, Chirieac, Lucian R., editor, Dacic, Sanja, editor, Borczuk, Alain C., editor, and Kerr, Keith M., editor

Published
2012
Full Text
View/download PDF

48. Lymph Nodes

Author

Allen, Timothy Craig, Cagle, Philip T., Allen, Timothy Craig, and Cagle, Philip T.

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results